3

Myriad Genetics, Inc. (NASDAQ:MYGN) went down by -1.61% from its latest closing price when compared to the 1-year high value of $50.44 and move down -13.22%, while MYGN stocks collected -0.62% of loss with the last five trading sessions.

Myriad Genetics, Inc. (NASDAQ:MYGN) Worth an Investment?

Myriad Genetics, Inc. (NASDAQ: MYGN) scored price to earnings ratio above its average ratio, recording 246.13 times of increase in earnings at the present.

MYGN Market Performance

MYGN stocks went down by -0.62% for the week, with the monthly jump of 70.95% and a quarterly performance of 67.61%, while its annual performance rate touched 4.75%. The simple moving average for the period of the last 20 days is 27.21% for MYGN stocks with the simple moving average of 45.58% for the last 200 days.

Analysts’ Opinion on Myriad Genetics, Inc. (NASDAQ:MYGN)

Many brokerage firms have already submitted their reports for MYGN stocks, with BofA/Merrill repeating the rating for MYGN shares by setting it to “Neutral”. The predicted price for MYGN socks in the upcoming period according to BofA/Merrill is $8 based on the research report published on August 2, 2019.

Barclays, on the other hand, stated in their research note that they expect to see MYGN stock at the price of $40, previously predicting the value of $18. The rating they have provided for MYGN stocks is “Equal Weight” according to the report published on August 1, 2019.

Needham gave “ Hold” rating to MYGN stocks, setting the target price at $40 in the report published on July 29, 2019.

MYGN Stocks 52.29% Far from 50 Day Moving Average

After a stumble in the market that brought MYGN to its low price for the period of the last 52 weeks, Myriad Genetics, Inc. was unable to take a rebound, for now settling with -11.68% of loss for the given period.

The stock volatility was left at 7.49%, however, within the period of a single month, the volatility rate increased by 4.19%, while the shares surge at the distance of +71.41% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +84.70% upper at the present time.

In the course of the last 5 trading sessions, MYGN went down by -0.62%, which changed the moving average for the period of 200 days to the total of +5.92% of gains for the stock in comparison to the 20-day moving average settled at $35.95. In addition, Myriad Genetics, Inc. saw 53.25% in overturn over the period of a single year with a tendency to cut further gains.

MYGN Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at Myriad Genetics, Inc. (MYGN), starting from King Gary A., who sold 60,000 shares at the price of $43.49 back on Aug 01. After this action, Rushing now owns 134,871 shares of Myriad Genetics, Inc., valued at $2,609,329 with the latest closing price.

Capone Mark Christopher, the President & C.E.O. of Myriad Genetics, Inc., sold 137,000 shares at the value of $44.00 during a trade that took place back on Aug 01, which means that Capone Mark Christopher is holding 440,833 shares at the value of $6,028,000 based on the most recent closing price.

MYGN Stock Fundamentals

The current profitability levels are settled at +7.44 for the present operating margin and +77.06 for gross margin. The net margin for Myriad Genetics, Inc. stands at +16.97. Total capital return value is set at 6.21, while invested capital returns managed to touch 14.16. Equity return holds the value 1.50%, with 1.00% for asset returns.

Based on Myriad Genetics, Inc. (MYGN), the company’s capital structure generated 0.96 points for debt to equity in total, while total debt to capital is set at the value of 0.95. Total debt to assets is settled at the value of 0.76 with long-term debt to equity ratio rests at 0.96 and long-term debt to capital is 0.95.

EBITDA value lies at +28.40 M with total debt to EBITDA carrying the value of 0.08. The value for Enterprise to Sales is 3.78 with debt to enterprise value settled at 0.00. The receivables turnover for Myriad Genetics, Inc. is 7.24 with the total asset turnover at the value of 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.19.